Original Article
The Spectrum of Solid Childhood Malignant Tumors in a Tertiary Health Care Institution.
1Sunday S Soyemi, 2Roland I Osuoji, 1John O Obafunwa, 1Olugbenga O Oyewole, 1Ayodele D Sanni, 11Festus E Emiogun
- 1 Department of Pathology and Forensic Medicine
- 2 Division of Paediatric Surgery, Department of Surgery, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.
- Submitted Saturday, January 25, 2014
- Accepted:Saturday, February 08, 2014
- Published Friday, September 05, 2014
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
Abstract
Background
Experts on malignant disease in childhood in the late thirties once stated that cancer is rare in childhood. Now, over seventy years later, childhood cancer is reported to be the leading cause of death in children between 1 and 15 years worldwide. Malignant tumors in infancy and childhood constitute about 2% of all malignant tumors. The objective of this study is to present the spectrum of childhood malignant tumors and compare our findings with similar reports from reliable institutions in other parts of the world.
Patients and method
This is a retrospective study of all cases of malignant tumors seen in children in our department over the last 5 years (from Jan 2008 to Dec 2012). Studies elsewhere had always included hematological malignancies such as lymphoma and leukemia which are relatively more common in pediatric age group. We therefore, decided to exclude hematological malignancies and focus on mesenchymal and other malignancies. The age in months, sex and histological diagnosis were recorded a pre-designed data form. All these were analyzed using the statistical package for social science (SPSS) Software version 20.
Results
Altogether 56 out of 2,610 cases representing 2.2% of all malignant tumors were seen in this study with females and males constituting 52% and 48% respectively. The male to female ratio (M: F) was approximately 1:1. Tumors were more common in children above 42 months of age and least common below 6 months. Wilms’ tumor accounted for 44%, while retinoblastoma accounted for 20%. Others included rhabdomyosarcoma (9%), malignant teratoma (8%) and Yolk sac tumor (5%).
Conclusion
Wilms’ tumor is the most common childhood malignant tumor at our centre. This is in agreement with almost all the studies done elsewhere. However, some variations exist in other centers.
Keywords
infancy, childhood, malignant tumor.
Introduction
Experts on malignant disease in childhood in the late thirties once stated that Cancer is rare in childhood [1]. Over seventy years later, childhood cancer is now reported to be the leading cause of death in children between 1 and 15 years worldwide [2 3].
The recent advances in treatment in the last couple of decades have however, resulted in improved cure rate especially among those who are treated in specialized care unit [4]. There has been a difficulty in estimating the overall incidence of childhood cancer in most parts of Africa, this is largely due to poor record keeping and inadequate diagnostic skills, nonetheless, differences in incidence between the southern and northern parts of Nigeria have been observed with the former being relatively higher [5 6]. Lower incidences ranging from 0.5% to 2% of all malignant tumors have been observed in Kenya, Tanzania and Ghana [7 8 9]. The objective of this study was to look at the spectrum of malignant childhood tumor and to compare the results on malignant childhood disease seen in this centre with similar reports from other centers in Africa and the World at large. Where there are disparities, attempts would be made to find explanations.
Material and methods
This is a retrospective study of the cases of malignant tumors seen in children in the Department of Pathology and Forensic Medicine in our tertiary health care institution over a 5- year period i.e. (from Jan 2008 to Dec 2012). This work is intended to concentrate solely on mesenchymal and germ cells tumors of children since almost all previous studies done on this work elsewhere had always included hematological malignancies. Hematological malignancies such as lymphoma and leukemia were therefore excluded from this study. Unspecified diagnosis such as undetermined malignancies, report of fine needle aspiration cytology and blood or fluid smears cytology were in addition excluded from this study so as to avoid ambiguity. The age in months, sex and histological diagnosis were recorded a pre-designed data form. All these were analyzed using the statistical package for social science (SPSS) Software version 20.
Result
Altogether 56 childhood malignancies were seen out of 2,610 cases representing 2.2% of all tumors in this study with females and males constituting 52% and 48% respectively. The male to female ratio (M: F) was approximately 1:1. Tumors were more common in children above 42 months of age and least common below 6 months. The only tumor seen in the neonatal period was retinoblastoma. The most common tumor was Wilms’ tumor which accounted for 44%, while Retinoblastoma accounted for 20%. Others included Malignant teratoma (8%), Rhabdomyosarcoma (9%), Yolk sac tumor (5%). See table 1.
table 1
Males
Females
|
27 (48)
29 (52)
|
AGE GROUP
<1 Month
1-6 months
7-12 months
13-18 months
19-24 months
37-42 months
Above 42 months
|
2 (4)
2 (4)
8 (14)
4 (7)
10 (18)
7 (12)
23 (41)
|
YEAR OF
DIAGNOSIS
2008
2009
2010
2011
2012
|
14 (25)
5 (9)
10 (18)
13 (23)
14 (25)
|
DIAGNOSIS
Wilms’ tumour
Retinoblastoma
Rhabdomyosarcoma
Yolk sac tumour
Malignant teratoma
Neuroblastoma
Others
|
25 (44)
11 (20)
5 (9)
3 (5)
4 (8)
2 (4)
6(10)
|
Discussion
The overall incidence of pediatric solid malignant tumors in Africa is difficult to estimate because of the lack of vital hospital statistics and partly by the absence of national childhood cancer registry in most countries including this country.
A major short fall in this study is the inability to determine the geographic and ethnic distributions. These unfortunately, might have assisted in relating the tumors to the genetic and environmental factors. Because of the present lack of immunohistochemical studies in this center, our diagnoses were based on the use of hematoxylin and eosin- stained slides.
In our study, 56 cases were seen over a 5- year period. This represented 11.2 cases per year. This is closely comparable to the study done in Calabar, South Eastern part of Nigeria which recorded annual rate of 12 cases [5]. These findings are however, slightly at variance with similar studies done in Lagos (24.8) [5], Zaria (17.1) [13s] and Jos (17.8) [6]. The highest recorded rate was found by Williams in 1975 in Ibadan [12], the Western part of Nigeria which reported annual rate of 100. This finding is also closely related to that found out by Welbec et al [7], in Korle Bu, Ghana which also reported a high figure of 76.8 cases per year. The very high figures in these two centers could have been due to unavailability of special diagnostics aids during that period.
Our findings that in South Eastern Nigeria [14] and South Western Nigeria [15] all showed that Wilms’ tumor and Retinoblastoma were among the top three common malignant tumors. Similar study in Kenya [10] showed preponderance of lymphoma followed by Retinoblastoma and Kaposi sarcoma. The prevalence of HIV infection in this region fully explains the high incidence of Kaposi sarcoma. Apart from lymphoma, retinoblastoma and Wilms’ tumors were the commonest tumors found in a study done by Mukiibi et al, in Malawi, East Africa [11]. This finding is in tandem with our results.
An interesting twist was however, observed in two centers in Northern Nigeria where Rhabdomyosarcoma was found to be the commonest malignant tumor [6 13]. The reason for this dramatic twist will be another area of research in the nearest future
We conclude that wilms’ tumor is the most common malignant tumor. This was followed by retinoblastoma in this center. These findings are in agreement with result of other centers.
Ethical Considerations
The study was approved by the Ethics committee.
Authors Contributions
SS: prepared the mauscript and involved in literature search
OR was responsible for the design, conceptualization of the
work and part of literature search
OJ
was responsible for the design, conceptualization of the work and part of
literature search
OO searched the records for the data and analyses
SS searched the records for the data and analyses
EF
searched the records for the data and analyses
Competing Interests
The authors declare that they have no competing interests.
Acknowledgements
We thank the department and the hospital authority for given us the approval to carry on this study. Special thanks also go to the technologist in the department who assisted in preparing new slides in cases of misplaced or broken ones.
Funding
None
References
[1]Dargeon HW: Malignant tumors in childhood. J. Paedia 1939;15: 317
[2]Arceci R, Ettinger A, Forman E, Haase GM, Hammond GD, Hoffman R, Kupst MJ, Link MP, Lustig CP, Traynor DS. National action plan for childhood cancer: report of the national action plan for childhood cancer.CA Cancer.J Clin.2002; 52:377-9[Pubmed]
[3]. Schofield D. Disease of infancy and childhood. In: Contran RS, Kumar V, Robbin L, editors. Robbins Pathologic Basis of Disease 8th ed.WB Saunders; 2006.p 222
[4]Ribeiro RC, Pui CH. saving the children –improving childhood cancer treatment in developing countries. N Engl J Med 2005; 352:2158-60
[5]Obioha FI, Kaine WN, Ikerionwu SE, Obi GO, Ulasi TO. The pattern of childhood malignancy in eastern Nigeria. Ann Trop Paediatr 1989;9:261-5[Pubmed]
[6].Tanko NM, Echejoh GO, Manasseh NA, Mandong MB, Uba A F. Pediatric solid tumors in Nigerian children: A changing pattern?. Afr J Paediatr Surg 2009;6:7-10[[Pubmed]
[7].Welbec JE, Hesse AA. Pattern of childhood malignancy in Korle Bu Teaching Hospital, Ghana. West Afr J Med 1999;17:81-4. [Pubmed]]
[8].Uba FA, Chirdan LB. Clinical characteristics and outcome of surgical treatment of childhood rhabdomyosarcoma: A 7-year experience. Afr J Paediatr Surg 2008;5:19-23.[Pubmed]
[9].Mgaya M, Kitinya JN. Histopathology of malignant childhood tumors in Tanzania. East Afr Med J 2000; 77:435-9. [Pubmed]
[10].Makata AM, Toriyamak Kamidigo NO, Eto H, Itakura H. The pattern of pediatric solid malignant tumor in western Kenya, East Africa,1979-1994: an analysis based on histopathological study. Am J Med Hyg 1996;54(4): 343-7 [Pubmed]
[11].Mukiibi JM, Banda L, Liomba NG, Sungani FC, Parkin DM. Spectrum of childhood cancer in Malawi 1985-1993. East Afr Med 1995.72(1): 25-9.[Pubmed]
[12].Williams AO. Tumors of childhood in Ibadan, Nigeria. Cancer 1975;36:370-8[Pubmed]
[13].Samaila MV. Malignant tumors of childhood in Zaria. Afr J Paediatri Surg 2009;6(1): 19-23 [Pubmed]
[14].Akhiwu WO, Igbe AP, Aligbe JU, Eze GI, Akang EE. Malignant Childhood solid tumors in Benin city, Nigeria. West Afr J Med 2009;28 (4): 222-6 [Pubmed]
[15].Agboola AO, Adekanbi FA, Musa AA et al. Pattern of childhood malignant tumors in a teaching hospital in south west Nigeria. Med J Aust.2009; 190(1):12-14 [Pubmed]